Circulating microRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment With Rituximab in Systemic Lupus Erythematosus Patients
Cecchi, I., et al. Circulating microRNAs as Potential Biomarkers for Monitoring the Response to In Vivo Treatment With Rituximab in Systemic Lupus Erythematosus Patients. Autoimmunity Reviews 2020; 9(202) article 102488 In Press
- Categories
- Reviews